REFERENCES
1. Suster S, Moran CA. Thymoma classification: current status and future trends. Am J Clin Pathol 2006;125:542-54.
2. Suster S, Moran CA. Histologic classification of thymoma: the World Health Organization and beyond. Hematol Oncol Clin North Am 2008;22:381-92.
3. Rosai J. Histological typing of tumors of the thymus, In: Rosai J, editor. World Health Organization International Histological Classification of Tumors. Berlin: Springer-Verlag; 1999.
4. . WHO classification of tumors editorial Board. Thoracic Tumors. WHO Classification of Tumors. Lyon: IARC; 2021.
5. Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. WHO classification of tumors of the lung, pleura, thymus and heart. World Health Classification of Tumors. Lyon: IARC; 2015.
6. Inoue M, Starostik P, Zettl A, et al. Correlating genetic aberrations with World Health Organization-defined histology and stage across the spectrum of thymomas. Cancer Res 2003;63:3708-15.
7. Petrini I, Meltzer PS, Kim IK, et al. A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. Nat Genet 2014;46:844-9.
8. Radovich M, Pickering CR, Felau I, et al. Cancer Genome Atlas Network. The integrated genomic landscape of thymic epithelial tumors. Cancer Cell 2018;33:244-258.e10.
9. Suster D, Miller JA, Pihan G, Mackinnon AC, Suster S. Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas. Mod Pathol 2021;34:1831-8.
10. Bernatz PE, Harrison EG, Claggett OT. Thymoma: a clinicopathologic study. J Thorac Cardiovasc Surg 1961;42:424-44.
11. Lattes R, Jonas S. Pathological and clinical features in 80 cases of thymoma. Bull N Y Acad Med 1957;33:145-7.
12. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981;48:2485-92.
13. Bernatz PE, Khonsari S, Harrison EG, Taylor WF. Thymoma: factors influencing prognosis. Surg Clin North Am 1973;53:885-92.
14. Chalabreysse L, Roy P, Cordier JF, Loire R, Gamondes JP, Thivolet-Bejui F. Correlation of the WHO schema for the classification of thymic epithelial neoplasms with prognosis: a retrospective study of 90 tumors. Am J Surg Pathol 2002;26:1605-11.
15. Rieker RJ, Hoegel J, Morresi-Hauf A, et al. Histologic classification of thymic epithelial tumors: comparison of established classification schemes. Int J Cancer 2002;98:900-6.
16. Pan C, Wu H, Yang C, Chen WY, Chiang H. The clinicopathological correlation of epithelial subtyping in thymoma: a study of 112 consecutive cases. Hum Pathol 1994;25:893-9.
17. Regnard J, Magdeleinat P, Dromer C, et al. Prognostic factors and long-term results after thymoma resection: a series of 307 patients. J Thorac Cardiovasc Surg 1996;112:376-84.
18. Marino M, Müller-Hermelink HK. Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus. Virchows Arch A Pathol Anat Histopathol 1985;407:119-49.
19. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Tumors of the lung, pleura, thymus and heart. World Health Organization Classification of Tumors. Lyon: IARC Press; 2004.
20. Ströbel P, Hartmann E, Rosenwald A, et al. Corticomedullary differentiation and maturational arrest in thymomas. Histopathology 2014;64:557-66.
21. Radovich M, Solzak JP, Hancock BA, et al. A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas. Br J Cancer 2016;114:477-84.
22. Suster D, Mackinnon AC, Pihan G, Everts R, Suster S. Lymphocyte-rich spindle cell thymoma: clinicopathologic, immunohistochemical, ultrastructural and molecular genetic study of 80 cases. Am J Surg Pathol 2022; doi: 10.1097/PAS.0000000000001855.
23. Suster S, Moran CA. Thymoma, atypical thymoma, and thymic carcinoma. A novel conceptual approach to the classification of thymic epithelial neoplasms. Am J Clin Pathol 1999;111:826-33.
24. Suster S, Moran CA. Primary thymic epithelial neoplasms showing combined features of thymoma and thymic carcinoma. A clinicopathologic study of 22 cases. Am J Surg Pathol 1996;20:1469-80.
25. Suster S, Moran CA. Spindle cell thymic carcinoma: clinicopathologic and immunohistochemical study of a distinctive variant of primary thymic epithelial neoplasm. Am J Surg Pathol 1999;23:691-700.
26. Quintanilla-martinez L, Wilkins EW, Ferry JA, Harris NL. Thymoma-morphologic subclassification correlates with invasiveness and immunohistologic features: a study of 122 cases. Hum Pathol 1993;24:958-69.
27. Suster DI, Craig Mackinnon A, DiStasio M, Basu MK, Pihan G, Suster S. Atypical thymomas with squamoid and spindle cell features: clinicopathologic, immunohistochemical and molecular genetic study of 120 cases with long-term follow-up. Mod Pathol 2022; doi: 10.1038/s41379-022-01013-x.
28. Gupta R, Marchevsky AM, McKenna RJ, et al. Evidence-based pathology and the pathologic evaluation of thymomas: transcapsular invasion is not a significant prognostic feature. Arch Pathol Lab Med 2008;132:926-30.
29. Roden AC, Yi ES, Jenkins SM, et al. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis. Am J Surg Pathol 2015;39:427-41.
30. Oselin K, Girard N, Lepik K, et al. Pathological discrepancies in the diagnosis of thymic epithelial tumors: the Tallinn-Lyon experience. J Thorac Dis 2019;11:456-64.
31. Verghese ET, den Bakker MA, Campbell A, et al. Interobserver variation in the classification of thymic tumours--a multicentre study using the WHO classification system. Histopathology 2008;53:218-23.
32. Wick MR. Prognostic factors for thymic epithelial neoplasms, with emphasis on tumor staging. Hematol Oncol Clin North Am 2008;22:527-42.
33. Kirschner T, Muller-Hermelink HK. In: Cecilia Fenoglio-Preiser M, Wolff M, Rilke F, editors. Progress in surgical pathology. Berlin, Heidelberg: Springer; 1989.
34. Giraud F, Fabien N, Auger C, Girod C, Loire R, Monier JC. Human thymic epithelial tumors: heterogeneity in immunostaining of epithelial cell markers and thymic hormones. Thymus 1990;15:15-29.
35. Hofmann WJ, Pallesen G, Möller P, Kunze WP, Kayser K, Otto HF. Expression of cortical and medullary thymic epithelial antigens in thymomas. An immunohistological study of 14 cases including a characterization of the lymphocytic compartment. Histopathology 1989;14:447-63.
36. Müller-Hermelink HK, Marino M, Palestro G, Schumacher U, Kirchner T. Immunohistological evidences of cortical and medullary differentiation in thymoma. Virchows Arch A Pathol Anat Histopathol 1985;408:143-61.
37. Suster S, Moran CA, Chan JK. Thymoma with pseudosarcomatous stroma: report of an unusual histologic variant of thymic epithelial neoplasm that may simulate carcinosarcoma. Am J Surg Pathol 1997;21:1316-23.
38. Yoneda S, Marx A, Heimann S, Shirakusa T, Kikuchi M, Müller-Hermelink HK. Low-grade metaplastic carcinoma of the thymus. Histopathology 1999;35:19-30.
